The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915 · see citing works

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238 · see citing works

Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients

Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · see citing works

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

Kahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799 · see citing works

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions

Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396 · see citing works

Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells

Woods, A., Dickerson, K., Heath, R. B., Hong, S. P., Momcilovic, M., Johnstone, S. R., Carlson, M., & Carling, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.06.005 · Cited by 1,395 · see citing works

Adiponectin and AdipoR1 Regulate PGC-1α and Mitochondria by Ca2+ and AMPK/SIRT1

Iwabu, M., Yamauchi, T., Okada-Iwabu, M., Sato, K., Nakagawa, T., Funata, M., Yamaguchi, M., Namiki, S., Nakayama, R., Tabata, M., et al. (2010) · Nature · doi:10.1038/nature08991 · Cited by 971 · see citing works

Rearrangements of the Cytoskeleton and Cell Contacts Induce Process Formation during Differentiation of Conditionally Immortalized Mouse Podocyte Cell Lines

Mundel, P. H., Reiser, J., Zúñiga, A., Pavenstädt, H., Davidson, G. R., Kriz, W., & Zeller, R. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3739 · Cited by 876 · see citing works

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757 · see citing works

Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade

Sanders, M. J., Grondin, P., Hegarty, B. D., Snowden, M. A., & Carling, D. (2007) · Biochemical Journal · doi:10.1042/bj20061520 · Cited by 667 · see citing works

Adiponectin regulates albuminuria and podocyte function in mice

Sharma, K., RamachandraRao, S., Qiu, G., Usui, H. K., Zhu, Y., Dunn, S., Ouedraogo, R., Hough, K., McCue, P. A., Chan, L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32691 · Cited by 607 · see citing works

Lipid Metabolism and Toxicity in the Heart

Goldberg, I. J., Trent, C. M., & Schulze, P. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.006 · Cited by 586 · see citing works

Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity

Tsuchida, A., Yamauchi, T., Ito, Y., Hada, Y., Maki, T., Takekawa, S., Kamon, J., Kobayashi, M., Suzuki, R., Hara, K., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402367200 · Cited by 550 · see citing works

Dissecting the Role of 5′-AMP for Allosteric Stimulation, Activation, and Deactivation of AMP-activated Protein Kinase

Suter, M., Riek, U., Tuerk, R. D., Schlattner, U., Wallimann, T., & Neumann, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606357200 · Cited by 479 · see citing works

Activation of the AMP-Activated Kinase by Antidiabetes Drug Metformin Stimulates Nitric Oxide Synthesis In Vivo by Promoting the Association of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase

Davis, B. J., Xie, Z., Viollet, B., & Zou, M. (2006) · Diabetes · doi:10.2337/diabetes.55.02.06.db05-1064 · Cited by 467 · see citing works

Diet-induced Obesity in C57BL/6J Mice Causes Increased Renal Lipid Accumulation and Glomerulosclerosis via a Sterol Regulatory Element-binding Protein-1c-dependent Pathway

Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387 · see citing works

Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK–SIRT1–PGC1α axis in db/db mice

Kim, M. Y., Lim, J. H., Youn, H. H., Hong, Y. A., Yang, K. S., Park, H., Chung, S., Koh, S. H., Shin, S. J., Choi, B. S., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2747-2 · Cited by 313 · see citing works

Adiponectin Suppression of High-Glucose–Induced Reactive Oxygen Species in Vascular Endothelial Cells

Ouedraogo, R., Wu, X., Xu, S., Fuchsel, L., Motoshima, H., Mahadev, K., Hough, K., Scalia, R. G., & Goldstein, B. J. (2006) · Diabetes · doi:10.2337/db05-1174 · Cited by 250 · see citing works

DGAT1 Expression Increases Heart Triglyceride Content but Ameliorates Lipotoxicity

Liu, L., Shi, X., Bharadwaj, K. G., Ikeda, S., Yamashita, H., Yagyu, H., Schaffer, J. E., Yu, Y., & Goldberg, I. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.049817 · Cited by 240 · see citing works

Screening, Monitoring, and Treatment of Albuminuria

de Jong, P. E., & Curhan, G. C. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010097 · Cited by 213 · see citing works

Adiponectin Activates AMP-Activated Protein Kinase in Muscle Cells via APPL1/LKB1-Dependent and Phospholipase C/Ca2+/Ca2+/Calmodulin-Dependent Protein Kinase Kinase-Dependent Pathways

Zhou, L., Deepa, S. S., Etzler, J. C., Ryu, J., Mao, X., Fang, Q., Liu, D. D., Torres, J. M., Jia, W., Lechleiter, J. D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028357 · Cited by 212 · see citing works

Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1

Rakatzi, I., Mueller, H., Ritzeler, O., Tennagels, N., & Eckel, J. (2004) · Diabetologia · doi:10.1007/s00125-003-1293-3 · Cited by 180 · see citing works

β-Glucan Fractions from Barley and Oats Are Similarly Antiatherogenic in Hypercholesterolemic Syrian Golden Hamsters

Delaney, B., Frazer, S. R., Hess, R., Ostergren, K., Haworth, J., Knutson, N., Nicolosi, R. J., Wilson, T. A., Carlson, T. L., & Zheng, G.-H. (2003) · Journal of Nutrition · doi:10.1093/jn/133.2.468 · Cited by 172 · see citing works

Endothelial-Podocyte Crosstalk: The Missing Link Between Endothelial Dysfunction and Albuminuria in Diabetes

Siddiqi, F. S., & Advani, A. (2013) · Diabetes · doi:10.2337/db13-0795 · Cited by 133 · see citing works

Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice

Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 118 · see citing works

Reduced Adiponectin Signaling Due to Weight Gain Results in Nonalcoholic Steatohepatitis Through Impaired Mitochondrial Biogenesis

Handa, P., Maliken, B. D., Nelson, J. E., Morgan‐Stevenson, V., Messner, D. J., Dhillon, B. K., Klintworth, H. M., Beauchamp, M. D., Yeh, M. M., Elfers, C., et al. (2013) · Hepatology · doi:10.1002/hep.26946 · Cited by 95 · see citing works

Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification

Wang, Y., Ma, X. L., & Lau, W. B. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.03.004 · Cited by 88 · see citing works

The role of adiponectin in renal physiology and development of albuminuria

Christou, G. A., & Kiortsis, D. N. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0578 · Cited by 86 · see citing works

Ronning After the Adiponectin Receptors

Holland, W. L., & Scherer, P. E. (2013) · Science · doi:10.1126/science.1249077 · Cited by 79 · see citing works

Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Tesaglitazar Attenuates Diabetic Nephropathy in db/db Mice

Cha, D. R., Zhang, X., Zhang, Y., Wu, J., Su, D., Han, J., Fang, X., Yu, B., Breyer, M. D., & Guan, Y. (2007) · Diabetes · doi:10.2337/db06-1134 · Cited by 76 · see citing works

Control of glycogen synthase through ADIPOR1-AMPK pathway in renal distal tubules of normal and diabetic rats

Cammisotto, P., Londoño, I., Gingras, D., & Bendayan, M. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00373.2007 · Cited by 72 · see citing works

Peroxisome proliferator-activated receptor-α activator fenofibrate prevents high-fat diet-induced renal lipotoxicity in spontaneously hypertensive rats

Shin, S. J., Lim, J. H., Chung, S., Youn, D., Chung, H. W., Kim, H. W., Lee, J. H., Chang, Y. S., & Park, C. W. (2009) · Hypertension Research · doi:10.1038/hr.2009.107 · Cited by 63 · see citing works

Role of PPARγ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential

Yang, J., Zhang, D., Li, J., Zhang, X., Fan, F., & Guan, Y. (2008) · Clinical Science · doi:10.1042/cs20070462 · Cited by 61 · see citing works

Relationship between visceral fat accumulation and urinary albumin-creatinine ratio in middle-aged Japanese men

Tamba, S., Nakatsuji, H., Kishida, K., Noguchi, M., Ogawa, T., Okauchi, Y., Nishizawa, H., Imagawa, A., Nakamura, T., Matsuzawa, Y., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.02.037 · Cited by 49 · see citing works

Adiponectin is expressed and secreted by renal tubular epithelial cells

Perri, A., Vizza, D., Lofaro, D., Gigliotti, P., Leone, F., Brunelli, E., Malivindi, R., Amicis, F. D., Romeo, F., Stefano, R. D., et al. (2013) · Journal of Nephrology · doi:10.5301/jn.5000269 · Cited by 40 · see citing works

Plasma adiponectin is related to the progression of kidney disease in type 2 diabetes patients

Kacsó, I. M., Bondor, C. I., & Kacsó, G. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2012.668928 · Cited by 34 · see citing works

Myocardial mitochondrial dysfunction in mice lacking adiponectin receptor 1

Koentges, C., König, A., Pfeil, K., Hölscher, M. E., Schnick, T., Wende, A. R., Schrepper, A., Cimolai, M. C., Kersting, S., Hoffmann, M. M., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0495-4 · Cited by 32 · see citing works

Analysis of the association between adiponectin, adiponectin receptor 1 and diabetic cardiomyopathy

LI, J., SU, S., & ZONG, X. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1539 · Cited by 22 · see citing works

Changes of adiponectin and its receptors in rats following chronic renal failure

Yu, Y., Bao, B., Fan, Y., Shi, L., & Li, S.-Q. (2013) · Renal Failure · doi:10.3109/0886022x.2013.830975 · Cited by 22 · see citing works

Damned If You Do, Damned If You Don’t: The Conundrum of Adipose Tissue Vascularization

Yilmaz, M., & Hotamışlıgil, G. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.12.014 · Cited by 17 · see citing works

Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities

Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363 · see citing works

Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism

Fu, Y., Sun, Y., Wang, M., Hou, Y., Huang, W. C., Zhou, D., Wang, Z., Yang, S., Tang, W., Zhen, J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.019 · Cited by 217 · see citing works

Diabetic fibrosis

Tuleta, I., & Frangogiannis, N. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.166044 · Cited by 216 · see citing works

Lipotoxicity in Kidney, Heart, and Skeletal Muscle Dysfunction

Nishi, H., Higashihara, T., & Inagi, R. (2019) · Nutrients · doi:10.3390/nu11071664 · Cited by 174 · see citing works

PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases

Lin, Y., Wang, Y., & Li, P. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1074911 · Cited by 146 · see citing works

Renal Lipid Metabolism and Lipotoxicity in Diabetes

Thongnak, L., Pongchaidecha, A., & Lungkaphin, A. (2019) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2019.11.004 · Cited by 132 · see citing works

Lipophagy deficiency exacerbates ectopic lipid accumulation and tubular cells injury in diabetic nephropathy

Han, Y., Xiong, S., Zhao, H., Yang, S., Yang, M., Zhu, X., Jiang, N., Xiong, X., Gao, P., Wei, L., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04326-y · Cited by 120 · see citing works

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease

Kim, Y., & Park, C. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071782 · Cited by 110 · see citing works

Prolyl Hydroxylase Domain Inhibitor Protects against Metabolic Disorders and Associated Kidney Disease in Obese Type 2 Diabetic Mice

Sugahara, M., Tanaka, S., Tanaka, T., Saito, H., Ishimoto, Y., Wakashima, T., Ueda, M., Fukui, K., Shimizu, A., Inagi, R., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060582 · Cited by 108 · see citing works

Obesity-related kidney disease: Beyond hypertension and insulin-resistance

Arabi, T. Z., Shafqat, A., Sabbah, B. N., Ashraf, N., Shah, H., Abdulkader, H. S., Razak, A., Sabbah, A. N., & Arabi, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1095211 · Cited by 98 · see citing works

The Contribution of Lipotoxicity to Diabetic Kidney Disease

Schelling, J. R. (2022) · Cells · doi:10.3390/cells11203236 · Cited by 86 · see citing works

Inhibition of miR-19a protects neurons against ischemic stroke through modulating glucose metabolism and neuronal apoptosis

Ge, X., Wang, J.-L., Liu, X., Zhang, J., Liu, C., & Guo, L. (2019) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-019-0160-2 · Cited by 83 · see citing works

Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function

Li, Z., Guo, H., Li, J. X., Ma, T., Zhou, S., Zhang, Z., Miao, L., & Cai, L. (2020) · Clinical Science · doi:10.1042/cs20191088 · Cited by 80 · see citing works

Adipocytokines: Are they the Theory of Everything?

Maximus, P., Achkar, Z. A., Hamid, P., Hasnain, S. S., & Peralta, C. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155144 · Cited by 77 · see citing works

Sex-related differences in diabetic kidney disease: A review on the mechanisms and potential therapeutic implications

Piani, F., Melena, I. L., Tommerdahl, K. L., Nokoff, N., Nelson, R. G., Pavkov, M. E., van Raalte, D. H., Cherney, D. Z. I., Johnson, R. J., Nadeau, K. J., et al. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107841 · Cited by 76 · see citing works

Interplay of lipid metabolism and inflammation in podocyte injury

Luo, Z., Chen, Z., Hu, J., & Ding, G. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155718 · Cited by 74 · see citing works

Adiponectin and Its Mimics on Skeletal Muscle: Insulin Sensitizers, Fat Burners, Exercise Mimickers, Muscling Pills … or Everything Together?

Abou-Samra, M., Selvais, C. M., Dubuisson, N., & Brichard, S. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072620 · Cited by 72 · see citing works

Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases

Liu, Y., Vu, V., & Sweeney, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00842 · Cited by 69 · see citing works

An updated pharmacological insight of resveratrol in the treatment of diabetic nephropathy

Li, K., Ji, M., & Sun, H. (2021) · Gene · doi:10.1016/j.gene.2021.145532 · Cited by 69 · see citing works

Lipid homeostasis in diabetic kidney disease

Wang, Y., Liu, T.-T., Wu, Y., Wang, L., Ding, S.-W., Hou, B., Zhao, H.-L., Liu, W.-J., & Li, P. (2024) · International Journal on Biological Sciences · doi:10.7150/ijbs.95216 · Cited by 72 · see citing works

Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.

Yang, S., Ma, C.-R., Wu, H., Zhang, H., Yuan, F., Yang, G., Yang, Q., Jia, L., Liang, Z., & Kang, L. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104678 · Cited by 68 · see citing works

Lipid metabolism disorder in diabetic kidney disease

Han, Y.-Z., Du, B., Zhu, X., Wang, Y.-Z.-Y., Zheng, H., & Liu, W. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1336402 · Cited by 73 · see citing works

Oxidative Stress Induced by Lipotoxicity and Renal Hypoxia in Diabetic Kidney Disease and Possible Therapeutic Interventions: Targeting the Lipid Metabolism and Hypoxia

Chae, S. Y., Kim, Y., & Park, C. W. (2023) · Antioxidants · doi:10.3390/antiox12122083 · Cited by 63 · see citing works

Disturbances in Insulin–Glucose Metabolism in Patients With Advanced Renal Disease With and Without Diabetes

Rahhal, M.-N., Gharaibeh, N. E., Rahimi, L., & Ismail‐Beigi, F. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00286 · Cited by 60 · see citing works

Obesity-Related Glomerulopathy: A Latent Change in Obesity Requiring More Attention

Yang, S., Cao, C., Deng, T., & Zhou, Z. (2020) · Kidney & Blood Pressure Research · doi:10.1159/000507784 · Cited by 60 · see citing works

Role of Perivascular Adipose Tissue-Derived Adiponectin in Vascular Homeostasis

Sówka, A., & Dobrzyń, P. (2021) · Cells · doi:10.3390/cells10061485 · Cited by 62 · see citing works

AdipoRon induces AMPK activation and ameliorates Alzheimer's like pathologies and associated cognitive impairment in APP/PS1 mice.

Khandelwal, M., Manglani, K., Upadhyay, P., Azad, M., & Gupta, S. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105876 · Cited by 55 · see citing works

Adiponectin receptor agonist AdipoRon ameliorates renal inflammation in diet-induced obese mice and endotoxin-treated human glomeruli ex vivo

Lindfors, S., Polianskyte-Prause, Z., Bouslama, R., Lehtonen, E., Mannerla, M., Nísen, H., Tienari, J., Salmenkari, H., Forsgård, R. A., Mirtti, T. K., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05473-9 · Cited by 54 · see citing works

The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease

Sun, Y., Cui, S., Hou, Y., & Yi, F. (2021) · Kidney Diseases · doi:10.1159/000518132 · Cited by 54 · see citing works

A review of recent advances on cyanidin-3-glucoside: the biotransformation, absorption, bioactivity and applications of nano-encapsulation

Yang, M., Abdullah, Ahmad, N., Hussain, M. H., Lu, X., Xu, J., Zhong, H., & Guan, R. (2023) · Food & Function · doi:10.1039/d2fo03824b · Cited by 54 · see citing works

Calcium Signaling Mediates Cell Death and Crosstalk with Autophagy in Kidney Disease

Ning, B., Guo, C., Kong, A., Li, K., Xie, Y., Shi, H., & Gu, J. (2021) · Cells · doi:10.3390/cells10113204 · Cited by 52 · see citing works

Adipokines as Clinically Relevant Therapeutic Targets in Obesity

Würfel, M., Blüher, M., Stümvoll, M., Ebert, T., Kovacs, P. L., Tönjes, A., & Breitfeld, J. (2023) · Biomedicines · doi:10.3390/biomedicines11051427 · Cited by 54 · see citing works

The role of adiponectin in cardiovascular disease

Peng, J., Chen, Q., & Wu, C. (2023) · Cardiovascular Pathology · doi:10.1016/j.carpath.2022.107514 · Cited by 50 · see citing works

Nanoparticle-mediated Klotho gene therapy prevents acute kidney injury to chronic kidney disease transition through regulating PPARα signaling in renal tubular epithelial cells

Li, H., Ouyang, Y., Lv, H., Liang, H., Luo, S., Zhang, Y., Mao, H., Chen, T., Chen, W., Zhou, Y., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122926 · Cited by 50 · see citing works

Fibroblast growth factor 21 coordinates adiponectin to mediate the beneficial effects of low-protein diet on primordial follicle reserve

Zhuo, Y., Hua, L., Feng, B., Jiang, X., Li, J., Jiang, D., Huang, X., Yingguo, Z., Li, Z., Yan, L., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.02.020 · Cited by 49 · see citing works

MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy

Zhou, H., Ni, W., Meng, X., & Tang, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.618536 · Cited by 49 · see citing works

AdipoRon and Other Adiponectin Receptor Agonists as Potential Candidates in Cancer Treatments

Nigro, E., Daniele, A., Salzillo, A., Ragone, A., Naviglio, S., & Sapio, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115569 · Cited by 46 · see citing works

An Adiponectin Receptor Agonist Reduces Type 2 Diabetic Periodontitis

Wu, X., Qiu, W., Hu, Z., Lian, J., Liu, Y., Zhu, X., Tu, M., Fang, F., Yu, Y., Valverde, P., et al. (2019) · Journal of Dental Research · doi:10.1177/0022034518818449 · Cited by 45 · see citing works

Comprehensive Lipidome Profiling of the Kidney in Early-Stage Diabetic Nephropathy

Hou, B., He, P., Ma, P., Yang, X., Xu, C., Lam, S. M., Shui, G., Yang, X., Zhang, L., Qiang, G., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00359 · Cited by 45 · see citing works

<scp>AdipoRon</scp>, a new therapeutic prospect for Duchenne muscular dystrophy

Abou‐Samra, M., Selvais, C. M., Boursereau, R., Lecompte, S., Noel, L., & Brichard, S. M. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12531 · Cited by 44 · see citing works

Tangshen Formula Attenuates Diabetic Nephropathy by Promoting ABCA1-Mediated Renal Cholesterol Efflux in db/db Mice

Liu, P., Peng, L., Zhang, H., Tang, P. M., Zhao, T., Yan, M., Zhao, H., Huang, X., Lan, H., & Li, P. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00343 · Cited by 44 · see citing works

AdipoRon: A Novel Insulin Sensitizer in Various Complications and the Underlying Mechanisms: A Review

Bhat, I. A., Kabeer, S. W., Reza, M. I., Mir, R. H., & Dar, M. O. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666191022102800 · Cited by 39 · see citing works

AdipoRon Affects Cell Cycle Progression and Inhibits Proliferation in Human Osteosarcoma Cells

Sapio, L., Nigro, E., Ragone, A., Salzillo, A., Illiano, M., Spina, A., Polito, R., Daniele, A., & Naviglio, S. (2020) · Journal of Oncology · doi:10.1155/2020/7262479 · Cited by 40 · see citing works

Chitosan oligosaccharide mitigates kidney injury in prediabetic rats by improving intestinal barrier and renal autophagy

Sutthasupha, P., Promsan, S., Thongnak, L., Pengrattanachot, N., Phengpol, N., Jaruan, O., Jaikumkao, K., Muanprasat, C., Pichyangkura, R., Chatsudthipong, V., et al. (2022) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2022.119405 · Cited by 39 · see citing works

Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone

Maalouf, N. M., POINDEXTER, J. R., ADAMS-HUET, B. A., Moe, O. W., & Sakhaee, K. (2019) · Kidney International · doi:10.1016/j.kint.2018.11.024 · Cited by 39 · see citing works

Adiponectin in renal fibrosis

Jing, H., Tang, S., Lin, S., Liao, M., Chen, H., Fan, Y., & Zhou, J. (2020) · Aging · doi:10.18632/aging.102811 · Cited by 39 · see citing works

A minireview: Role of AMP-activated protein kinase (AMPK) signaling in obesity-related renal injury

Zhuo, L., Li, J. X., Miao, X., Cui, W., Miao, L., & Cai, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118828 · Cited by 40 · see citing works

PPAR-α Agonist Fenofibrate Prevented Diabetic Nephropathy by Inhibiting M1 Macrophages via Improving Endothelial Cell Function in db/db Mice

Feng, X., Gao, X., Wang, S., Huang, M., Sun, Z., Dong, H., Yu, H., & Wang, G. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.652558 · Cited by 39 · see citing works

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Zhang, Z., Ni, L., Zhang, L., Zha, D., Hu, C., Zhang, L., Feng, H. A., Wei, X., & Wu, X. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s289712 · Cited by 38 · see citing works

AdipoRon ameliorates the progression of heart failure with preserved ejection fraction via mitigating lipid accumulation and fibrosis

Tan, W., Wang, Y., Cheng, S., Liu, Z., Xie, M., Song, L., Qiu, Q., Wang, X., Li, Z., Liu, T., et al. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.02.015 · Cited by 37 · see citing works

The dual role of lipids in chronic kidney disease: Pathogenic culprits and therapeutic allies

Giardini, E., Moore, D., Sadlier, D. M., Godson, C., & Brennan, E. P. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118615 · Cited by 36 · see citing works

Adiponectin for the treatment of diabetic nephropathy

Lee, J. Y., Yang, J. W., Han, B. G., Choi, S. O., & Kim, J. S. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.109 · Cited by 37 · see citing works

Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice

Zhao, J., He, K., Du, H., Wei, G., Wen, Y., Wang, J., Zhou, X., & Wang, J. (2022) · PeerJ · doi:10.7717/peerj.13932 · Cited by 34 · see citing works

Sex differences in obesity-induced renal lipid accumulation revealed by lipidomics: a role of adiponectin/AMPK axis

Juszczak, F., Pierre, L., Decarnoncle, M., Jadot, I., Martin, B., Botton, O., Caron, N., Dehairs, J., Swinnen, J. V., & Declèves, A. (2023) · Biology of Sex Differences · doi:10.1186/s13293-023-00543-6 · Cited by 35 · see citing works

High Fat Diet Induces Kidney Injury via Stimulating Wnt/β-Catenin Signaling

Yu, Y., Mo, H., Zhuo, H., Chen, Y., & Liu, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.851618 · Cited by 33 · see citing works

Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases

Huang, W., Chen, Y., Li, Z., He, F., & Zhang, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810882 · Cited by 32 · see citing works

Astragalus membranaceus and Panax notoginseng, the Novel Renoprotective Compound, Synergistically Protect against Podocyte Injury in Streptozotocin-Induced Diabetic Rats

Zhai, R., Jian, G., Chen, T., Xie, L., Xue, R., Gao, C., Wang, N., Xu, Y., & Gui, D. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1602892 · Cited by 32 · see citing works

Early diabetic kidney disease: Focus on the glycocalyx

Yu, H., Song, Y.-Y., & Li, X. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.460 · Cited by 32 · see citing works

ALY688 elicits adiponectin-mimetic signaling and improves insulin action in skeletal muscle cells

Sung, H. K., Mitchell, P. L., Gross, S. M., Marette, A., & Sweeney, G. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00603.2020 · Cited by 30 · see citing works

Distribution of Adiponectin Receptors in the Brain of Adult Mouse: Effect of a Single Dose of the Adiponectin Receptor Agonist, AdipoRON, on Ischemic Stroke

Clain, J., Couret, D., Planesse, C., Trotot, P. K., Meilhac, O., d’Hellencourt, C. L., Viranaïcken, W., & Diotel, N. (2022) · Brain Sciences · doi:10.3390/brainsci12050680 · Cited by 31 · see citing works

Protective effect of melatonin against metabolic disorders and neuropsychiatric injuries in type 2 diabetes mellitus mice

Gao, X., Sun, H., Wei, Y.-D., Niu, J., Hao, S., Sun, H., Tang, G., Qi, C., & Ge, J. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155805 · Cited by 30 · see citing works

Small extracellular vesicles-shuttled miR-23a-3p from mesenchymal stem cells alleviate renal fibrosis and inflammation by inhibiting KLF3/STAT3 axis in diabetic kidney disease

Li, Q., Liu, J., Su, R., Zhen, J., Liu, X., & Liu, G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112667 · Cited by 30 · see citing works

The intricate role of adipokines in cancer-related signaling and the tumor microenvironment: Insights for future research

Kounatidis, D. C., Vallianou, N. G., Karampela, Ι., Grivakou, E., & Dalamaga, Μ. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.05.013 · Cited by 30 · see citing works

Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies

Xu, Y., Zhu, H., Li, W., Chen, D., Xu, Y., Xu, A., & Ye, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108284 · Cited by 30 · see citing works

Overexpression of adiponectin alleviates intracerebral hemorrhage-induced brain injury in rats via suppression of oxidative stress

Wang, S., Li, D., Huang, C., Wan, Y., Wang, J., Zan, X., & Yang, B. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.05.050 · Cited by 29 · see citing works

Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives

Drapkina, O. M., Elkina, A. Y., Sheptulina, A. F., & Kiselev, A. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098445 · Cited by 29 · see citing works

AdipoRon Alleviates Free Fatty Acid-Induced Myocardial Cell Injury Via Suppressing Nlrp3 Inflammasome Activation

Zhang, Y., Zhang, Y.-L., Huang, Q., Huang, C., Jiang, Z., Cai, F., & Shen, J. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s221841 · Cited by 28 · see citing works

Chemical Synthesis and Biological Evaluations of Adiponectin Collagenous Domain Glycoforms

Wu, H., Zhang, Y., Li, Y., Xu, J., Wang, Y., & Li, X. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c02382 · Cited by 28 · see citing works

Adiponectin receptors by increasing mitochondrial biogenesis and respiration promote osteoblast differentiation: Discovery of isovitexin as a new class of small molecule adiponectin receptor modulator with potential osteoanabolic function

Pal, S., Singh, M., Porwal, K., Rajak, S., Das, N., Rajput, S., Trivedi, A. K., Maurya, R., Sinha, R. A., Siddiqi, M. I., et al. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174634 · Cited by 28 · see citing works

Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future

Mallik, R., & Chowdhury, T. A. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221081601 · Cited by 28 · see citing works

Adiponectin Reduces Glomerular Endothelial Glycocalyx Disruption and Restores Glomerular Barrier Function in a Mouse Model of Type 2 Diabetes

Fawaz, S., Alonso, A. M., Qiu, Y., Ramnath, R. D., Stowell-Connolly, H., Gamez, M., May, C., Down, C. J., Coward, R. J., Butler, M. J., et al. (2024) · Diabetes · doi:10.2337/db23-0455 · Cited by 29 · see citing works

PEGylated AdipoRon derivatives improve glucose and lipid metabolism under insulinopenic and high-fat diet conditions

Onodera, T., Zadeh, E. H. G., Xu, P. H., Gordillo, R., Guo, Z., Joffin, N., Yu, B., Scherer, P. E., & Li, W. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100095 · Cited by 26 · see citing works

Ceramides and Acute Kidney Injury

Nicholson, R. J., Holland, W. L., & Summers, S. A. (2022) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2022.10.007 · Cited by 25 · see citing works

Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury

Su, J., Ye, D., Gao, C., Huang, Q., & Gui, D. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05749-0 · Cited by 25 · see citing works

The role of perirenal adipose tissue deposition in chronic kidney disease progression: Mechanisms and therapeutic implications

Qiu, X., Lan, X., Li, L., Chen, H., ZHANG, N., Zheng, X., & Xie, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122866 · Cited by 24 · see citing works

Melatonin Attenuates Diabetic Myocardial Microvascular Injury through Activating the AMPK/SIRT1 Signaling Pathway

Wang, B., Li, J., Bao, M., Chen, R., Li, H., Lu, B., Chen, M., Huang, D., Zhang, Y., Gao, F., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8882130 · Cited by 23 · see citing works

Upregulation of Nrf2 and Decreased Redox Signaling Contribute to Renoprotective Effects of Chemerin Receptor Blockade in Diabetic Mice

Neves, K. B., Montezano, A. C., Alves-Lopes, R., Bruder-Nascimento, T. B., da Costa, R. M., Costa, R. S., Touyz, R. M., & Tostes, R. C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082454 · Cited by 23 · see citing works

Radix Astragali and Its Representative Extracts for Diabetic Nephropathy: Efficacy and Molecular Mechanism

Xue, H.-Z., Chen, Y., Wang, S.-D., Yang, Y.-M., Cai, L.-Q., Zhao, J., Huang, W., & Xiao, Y. (2024) · Journal of Diabetes Research · doi:10.1155/2024/5216113 · Cited by 22 · see citing works

A novel adiponectin receptor agonist (AdipoAI) ameliorates type 2 diabetes‐associated periodontitis by enhancing autophagy in osteoclasts.

Wu, X., Sun, Y., Cui, R., Qiu, W., Zhang, J., Hu, Z., Bi, W., Yang, F., Ma, D., Dyke, T. E. V., et al. (2022) · Journal of Periodontal Research · doi:10.1111/jre.12969 · Cited by 22 · see citing works

AdipoRon, an adiponectin receptor agonist, protects contrast-induced nephropathy by suppressing oxidative stress and inflammation via activation of the AMPK pathway

Gu, D., Shi, Y., Gong, Z., Xia, T., Ren, H., He, D., Yang, J., Han, Y., & Zeng, C. (2020) · Clinical and Experimental Nephrology · doi:10.1007/s10157-020-01944-2 · Cited by 21 · see citing works

A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease

Wang, Y., Liu, T., Ma, F., Lu, X., Mao, H., Zhou, W., Yang, L., Li, P., & Zhan, Y. (2020) · Journal of Diabetes Research · doi:10.1155/2020/2421631 · Cited by 21 · see citing works

Serum isthmin-1 levels are positively and independently correlated with albuminuria in patients with type 2 diabetes mellitus

Wang, C., Xu, M., Feng, R., Zhang, L., Yin, X., Feng, R., Liang, K., & Liu, J. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-002972 · Cited by 20 · see citing works

Current updates on metabolites and its interlinked pathways as biomarkers for diabetic kidney disease: A systematic review

Das, S., Rajeswari, V. D., Venkatraman, G., Elumalai, R., Sivaraman, D., & Ramanathan, G. (2023) · Translational research · doi:10.1016/j.trsl.2023.11.002 · Cited by 20 · see citing works

Advances in understanding the role of adiponectin in renal fibrosis

Zhao, D., Zhu, X., Jiang, L., Huang, X., Zhang, Y., Wei, X. S., Zhao, X., & Du, Y. (2020) · Nephrology · doi:10.1111/nep.13808 · Cited by 19 · see citing works

Anti-Obesity Effect of Erigeron annuus (L.) Pers. Extract Containing Phenolic Acids

Zheng, Y., Choi, Y., Lee, J., Lee, S.-Y., & Kang, I. (2021) · Foods · doi:10.3390/foods10061266 · Cited by 19 · see citing works

Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs

Wang, W., Bale, S., Wei, J., Yalavarthi, B., Bhattacharyya, D., Yan, J. J., Abdala‐Valencia, H., Xu, D., Sun, H., Marangoni, R. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33767-y · Cited by 19 · see citing works

A novel small molecule AdipoR2 agonist ameliorates experimental hepatic steatosis in hamsters and mice

Zhao, Y., Sun, N., Song, X., Zhu, J., Wang, T., Wang, Z., Yu, Y., Ren, J. L., Chen, H., Zhan, T., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.04.001 · Cited by 18 · see citing works

Curcumin targets CXCL16-mediated podocyte injury and lipid accumulation in diabetic kidney disease treatment

Chen, Y., Tao, J., He, Y., Hou, X.-D., Ji, F., Huang, J., Wang, L., Shen, J., Zhu, B., Wang, N., et al. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01521-1 · Cited by 19 · see citing works

C1q/Tumor Necrosis Factor-Related Protein-9 Attenuates Diabetic Nephropathy and Kidney Fibrosis in db/db Mice

Hu, H., Li, W., Liu, M., Xiong, J., Li, Y., Wei, Y., Huang, C., & Tang, Y. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5302 · Cited by 19 · see citing works

Insights Into the Controversial Aspects of Adiponectin in Cardiometabolic Disorders

Francischetti, E. A., Dezonne, R. S., Pereira, C. M., Martins, C. J. D. M., Celoria, B. M. J., de Oliveira, P. A. C., & de Abreu, V. G. (2020) · Hormone and Metabolic Research · doi:10.1055/a-1239-4349 · Cited by 19 · see citing works

Adiponectin in Myopathies

Gamberi, T., Magherini, F., & Fiaschi, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071544 · Cited by 18 · see citing works

Organophosphorus Flame Retardants and Metabolic Disruption: An in Silico , in Vitro , and in Vivo Study Focusing on Adiponectin Receptors

Liu, Y., Ma, X., Le, Y., Feng, J., Xu, M., Wang, W., & Wang, C. (2024) · Environmental Health Perspectives · doi:10.1289/ehp14634 · Cited by 18 · see citing works

Exploring the logic and conducting a comprehensive evaluation of AdipoRon-based adiponectin replacement therapy against hormone-related cancers—a systematic review

Laurindo, L. F., Sosin, A. F., Lamas, C. B., Goulart, R. D. Á., Haber, J. F. D. S., Detregiachi, C. R. P., & Barbalho, S. M. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02792-z · Cited by 18 · see citing works

A sulfonamide chalcone AMPK activator ameliorates hyperglycemia and diabetic nephropathy in db/db mice

Kaewin, S., Poolsri, W., Korkut, G. G., Patrakka, J., Aiebchun, T., Rungrotmongkol, T., Sungkaworn, T., Sukanadi, I. P., Chavasiri, W., & Muanprasat, C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115158 · Cited by 17 · see citing works

CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice

Zuo, F., Liu, Z.-Y., Wang, M., Du, J., Ding, P.-Z., Zhang, H., Tang, W., Sun, Y., Wang, X., Zhang, Y., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01213-4 · Cited by 17 · see citing works

Podocyte SIRPα reduction in diabetic nephropathy aggravates podocyte injury by promoting pyruvate kinase M2 nuclear translocation

Chen, Y., Zhang, M., Jia, R., Qian, B., Jing, C., Caihong, Z., Zhu, D., Liu, Z., Zen, K., & Li, L. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103439 · Cited by 17 · see citing works

Stigmasterol and gastrodin, two major components of banxia-baizhu-tianma decoction, alleviated the excessive phlegm-dampness hypertension by reducing lipid accumulation

Zhang, H., Sun, Y., Zou, Y., Chen, C., & Wang, S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117193 · Cited by 16 · see citing works

AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice

Choi, S.-K., Kwon, Y., Byeon, S., Haam, C. E., & Lee, Y.-H. (2020) · PLOS ONE · doi:10.1371/journal.pone.0230227 · Cited by 15 · see citing works

Adiponectin ameliorates hypertrophic scar by inhibiting Yes-associated protein transcription through SIRT1-mediated deacetylation of C/EBPβ and histone H3

Zhang, J., Li, Y., Liu, J., Han, F., Shi, J., Wu, G., Wang, K., Shen, K., Zhao, M., Gao, X., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105236 · Cited by 15 · see citing works

AdipoRon Protects against Tubular Injury in Diabetic Nephropathy by Inhibiting Endoplasmic Reticulum Stress

Xiong, S., Han, Y., Gao, P., Zhao, H., Jiang, N., & Sun, L. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6104375 · Cited by 13 · see citing works

Adiponectin receptor agonist AdipoRon decreased ceramide, and lipotoxicity, and ameliorated diabetic nephropathy

Choi, S. R., Lim, J. H., Kim, M. Y., Kim, E. N., Kim, Y., Choi, B. S., Kim, Y.-S., Kim, H. W., Lim, K., Kim, M.-J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.004 · Cited by 147 · see citing works

Resveratrol increases AdipoR1 and AdipoR2 expression in type 2 diabetic nephropathy

Park, H. S., Lim, J. H., Kim, M. Y., Kim, Y., Hong, Y. A., Choi, S. R., Chung, S., Kim, H. W., Choi, B. S., Kim, Y., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0922-9 · Cited by 107 · see citing works

Intraperitoneal administration of the globular adiponectin gene ameliorates diabetic nephropathy in Wistar rats

Fang, Y., Liu, Y., LIU, F.-Y., Peng, Y.-M., & TIAN, J.-W. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2133 · Cited by 24 · see citing works

Mechanisms of Adiponectin Action: Implication of Adiponectin Receptor Agonism in Diabetic Kidney Disease

Kim, Y., & Park, C. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071782 · Cited by 110 · see citing works